mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to Pegaspargase

G. Koo; S. Anvari; D.L. Friedman; S. Zarnegar-Lumley; V. Szafron; B.M. Kahwash; K.M. Onasch; L. Hall; E.J. Phillips; C.A. Stone

doi:10.1016/j.jaip.2021.09.051

Back

mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to Pegaspargase

Journal article

Open access

Peer reviewed

mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to Pegaspargase

G. Koo, S. Anvari, D.L. Friedman, S. Zarnegar-Lumley, V. Szafron, B.M. Kahwash, K.M. Onasch, L. Hall, E.J. Phillips and C.A. Stone

The Journal of Allergy and Clinical Immunology: In Practice, Vol.10(1), pp.P322-P325

2021

DOI: https://doi.org/10.1016/j.jaip.2021.09.051

Files and links (2)

pdf

mRNA.pdfDownload View

Author’s Version Open Access

url

Link to Published Version *Subscription may be requiredView

Abstract

Pegaspargase is a vital component of a multidrug chemotherapy regimen for treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LL)...

Details

Title: mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to Pegaspargase
Authors/Creators: G. Koo (Author/Creator) - Vanderbilt University Medical Center
S. Anvari (Author/Creator) - Baylor College of Medicine
D.L. Friedman (Author/Creator) - Vanderbilt University Medical Center
S. Zarnegar-Lumley (Author/Creator) - Vanderbilt University Medical Center
V. Szafron (Author/Creator) - Baylor College of Medicine
B.M. Kahwash (Author/Creator) - Vanderbilt University Medical Center
K.M. Onasch (Author/Creator) - Vanderbilt University Medical Center
L. Hall (Author/Creator) - Monroe Carell Jr. Children's Hospital
E.J. Phillips (Author/Creator) - Vanderbilt University
C.A. Stone (Author/Creator)
Publication Details: The Journal of Allergy and Clinical Immunology: In Practice, Vol.10(1), pp.P322-P325
Publisher: Elsevier
Identifiers: 991005543883807891
Copyright: © 2021 Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
Murdoch Affiliation: Institute for Immunology and Infectious Diseases
Language: English
Resource Type: Journal article

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Metrics

41 File views/ downloads

76 Record Views

20 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.75 Blood Clotting; 1.75.2119 Heparin-Induced Thrombocytopenia
Web Of Science research areas: Allergy; Immunology
ESI research areas: Clinical Medicine